<DOC>
	<DOCNO>NCT02961855</DOCNO>
	<brief_summary>Double-blinded multicenter randomize clinical trial evaluate efficacy safety CLIFE2 ( lidocaine , refer treatment A ) respect CLIFE1 ( lidocaine plus diclofenac , refer treatment B ) benign anorectal surgery .</brief_summary>
	<brief_title>Efficacy Safety CLIFE1 Gel Benign Anorectal Surgery</brief_title>
	<detailed_description>120 patient randomly assign two group ( 60 group ) . The study conduct two parallel group , 1:1 randomization stratify type surgery centre . Treatment CLIFE 1 CLIFE 2 apply day 1 day 6 post-surgery</detailed_description>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Hemorrhoids</mesh_term>
	<mesh_term>Rectal Fistula</mesh_term>
	<mesh_term>Fissure Ano</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Patients undergo benign anorectal surgery ( inpatient ) , follow diagnosis : anal fissure , fistula , hemorrhoid Use subarachnoid anesthesia lidocaine Allergy Hypersensitivity lidocaine local anesthesics . Patients accept subarachnoid anesthesia Patients general anesthesia Hypersensitivity contraindication acetylsalicylic acid . History gastrointestinal hemorrhage perforation due nonsteroidal antiinflammatory drug ( NSAIDs ) use Active relapsing peptic ulcer/gastrointestinal hemorrhage Serious heart failure . Active Crohn disease Active ulcerative colitis Moderate sever renal failure Severe liver disfunction Coagulation disorder require treatment anticoagulant drug Proctitis ( due autoimmune disease , foreign substance , sucally transmitted disease Treatment : Beta blocker , calcium channel blocker ( verapamil diltiazem ) , antiarrhythmic ( digoxin , amiodarone ) , ivabradine , lithium , steroid Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>